Welcome to our dedicated page for ICON plc SEC filings (Ticker: ICLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ICON plc filings document current-report disclosures for a foreign private issuer in the clinical research organization sector. Form 6-K reports furnish press releases and exhibits on operating results, financial guidance, earnings-call scheduling, conference presentations, shareholder voting matters, governance updates, and clinical or regulatory disclosures.
The filings also record accounting-practices and internal-control matters, including revenue-recognition disclosures, as well as XBRL financial information covering operating results, equity accounts and reporting-segment data. These documents frame ICON’s public-company reporting around clinical development services, capital structure, governance and risk-related material events.
ICON plc is delaying the release of its fourth quarter and full year 2025 earnings, now planning to report on or prior to April 30, 2026. The company’s audit committee has launched an internal investigation, led by outside counsel and forensic and technical accounting firms, into certain accounting practices and controls, primarily around revenue recognition for 2023 through 2025.
ICON is reviewing the design and operation of its internal controls over financial reporting and expects to report one or more material weaknesses. Preliminary indications are that revenue in 2023 and 2024 may have been overstated by less than two percent for each fiscal year. Because of the investigation and related reporting delays, ICON is withdrawing its previously issued 2025 full year financial guidance and is not yet able to communicate 2025 financial performance. The company states the investigation has not identified any impact to customers from the practices under review.
ICON plc filed a Form 6-K as a foreign private issuer for November 2025. The filing mainly furnishes an exhibit stating that ICON plc will present at the Jefferies London Healthcare Conference.
The report confirms ICON files annual reports on Form 20-F and is signed by Chief Financial Officer Nigel Clerkin on November 12, 2025.
ICON plc (ICLR) filed a Form 6‑K with Q3 2025 results and updates. Revenue was $2,042,812 thousand for the quarter and $6,061,501 thousand for the nine months. Q3 net income was $2,355 thousand (basic EPS $0.03) versus $197,128 thousand a year ago, driven by a non‑cash goodwill impairment of $165,300 thousand recorded in the quarter. Income from operations was $86,584 thousand versus $285,434 thousand in Q3 2024.
The company executed significant buybacks: 4,504,330 shares were redeemed in 2025 for $750,000 thousand in total consideration, with remaining authorization of $750,000 thousand as of October 23, 2025. Cash and cash equivalents were $468,888 thousand, and total debt was $3,424,129 thousand at September 30, 2025. Net cash provided by operating activities for the nine months was $802,043 thousand.
ICON recorded restructuring charges of $82,296 thousand year‑to‑date and improved accumulated other comprehensive loss to $(86,944) thousand. Unsatisfied performance obligations were approximately $14.0 billion, with 51% expected to be recognized over the next 12 months. The company noted a BARDA stop work notice affected a large COVID vaccine study, with about half of the planned 10,000 participants enrolled and continued follow‑up per protocol.
ICON plc (ICLR) insider filed a Form 144 to sell 18,901 common shares with an aggregate market value of $3,594,781.19. The shares are scheduled for sale on or about 10/02/2025 on NASDAQ.
The filing shows the 18,901 shares were acquired on 10/01/2025 as restricted stock that vested under a registered plan and were issued by the issuer for services rendered. The filing reports 77,772,130 shares outstanding and indicates no securities sold by the filer in the past three months.
ICON plc filed a Form 6-K as a foreign private issuer for September 2025. The filing mainly provides an exhibit stating that ICON plc has scheduled its third quarter 2025 earnings conference call. The report is signed on behalf of the company by Chief Financial Officer Nigel Clerkin.
ICON plc submitted a Form 6-K as a foreign private issuer for September 2025, mainly to provide investors with a press release about a CEO transition.
The filing lists a single exhibit, a press release dated September 4, 2025 titled “ICON Announces CEO Transition,” indicating a planned leadership change at the chief executive level, though specific details of the transition are contained in the attached press release rather than this summary document.
ICON plc, an Ireland-based company, submitted a routine report as a foreign private issuer and indicated it files its annual reports on Form 20-F. The report mainly highlights that ICON plc plans to participate in upcoming investor conferences, signaling continued engagement with the investment community.